PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CPRX vs. FLGT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


CPRXFLGT
YTD Return-7.26%-29.89%
1Y Return18.74%-45.07%
3Y Return (Ann)39.40%-36.80%
5Y Return (Ann)34.28%29.39%
Sharpe Ratio0.41-1.23
Daily Std Dev43.58%36.12%
Max Drawdown-94.25%-89.62%
Current Drawdown-25.94%-88.97%

Fundamentals


CPRXFLGT
Market Cap$1.81B$566.47M
EPS$0.56-$5.56
PE Ratio27.389.30
PEG Ratio0.001.32
Total Revenue (TTM)$411.35M$287.53M
Gross Profit (TTM)$347.75M$103.80M
EBITDA (TTM)$114.04M-$46.34M

Correlation

-0.50.00.51.00.2

The correlation between CPRX and FLGT is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

CPRX vs. FLGT - Performance Comparison

In the year-to-date period, CPRX achieves a -7.26% return, which is significantly higher than FLGT's -29.89% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


200.00%400.00%600.00%800.00%1,000.00%1,200.00%1,400.00%2024FebruaryMarchAprilMayJune
1,291.96%
120.81%
CPRX
FLGT

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Catalyst Pharmaceuticals, Inc.

Fulgent Genetics, Inc.

Risk-Adjusted Performance

CPRX vs. FLGT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Fulgent Genetics, Inc. (FLGT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CPRX
Sharpe ratio
The chart of Sharpe ratio for CPRX, currently valued at 0.41, compared to the broader market-2.00-1.000.001.002.003.000.41
Sortino ratio
The chart of Sortino ratio for CPRX, currently valued at 0.85, compared to the broader market-4.00-2.000.002.004.006.000.85
Omega ratio
The chart of Omega ratio for CPRX, currently valued at 1.11, compared to the broader market0.501.001.502.001.11
Calmar ratio
The chart of Calmar ratio for CPRX, currently valued at 0.40, compared to the broader market0.002.004.006.000.40
Martin ratio
The chart of Martin ratio for CPRX, currently valued at 1.52, compared to the broader market0.0010.0020.001.52
FLGT
Sharpe ratio
The chart of Sharpe ratio for FLGT, currently valued at -1.23, compared to the broader market-2.00-1.000.001.002.003.00-1.23
Sortino ratio
The chart of Sortino ratio for FLGT, currently valued at -1.93, compared to the broader market-4.00-2.000.002.004.006.00-1.93
Omega ratio
The chart of Omega ratio for FLGT, currently valued at 0.77, compared to the broader market0.501.001.502.000.77
Calmar ratio
The chart of Calmar ratio for FLGT, currently valued at -0.50, compared to the broader market0.002.004.006.00-0.50
Martin ratio
The chart of Martin ratio for FLGT, currently valued at -1.22, compared to the broader market0.0010.0020.00-1.22

CPRX vs. FLGT - Sharpe Ratio Comparison

The current CPRX Sharpe Ratio is 0.41, which is higher than the FLGT Sharpe Ratio of -1.23. The chart below compares the 12-month rolling Sharpe Ratio of CPRX and FLGT.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.002024FebruaryMarchAprilMayJune
0.41
-1.23
CPRX
FLGT

Dividends

CPRX vs. FLGT - Dividend Comparison

Neither CPRX nor FLGT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CPRX vs. FLGT - Drawdown Comparison

The maximum CPRX drawdown since its inception was -94.25%, which is greater than FLGT's maximum drawdown of -89.62%. Use the drawdown chart below to compare losses from any high point for CPRX and FLGT. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%2024FebruaryMarchAprilMayJune
-25.94%
-88.97%
CPRX
FLGT

Volatility

CPRX vs. FLGT - Volatility Comparison

Catalyst Pharmaceuticals, Inc. (CPRX) and Fulgent Genetics, Inc. (FLGT) have volatilities of 8.86% and 8.57%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%2024FebruaryMarchAprilMayJune
8.86%
8.57%
CPRX
FLGT

Financials

CPRX vs. FLGT - Financials Comparison

This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Fulgent Genetics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items